Showing results (581-590 of 787) with videos related to

Sort By:
Pageof 79
Clinical Biochemistry|March 13, 1999
Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classificationG H Borchert, D N Melegos, H Yu, et al.
British Journal of Cancer|July 17, 2015
Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancerD Korbakis, A Dimitromanolakis, I Prassas, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndromeC V Obiezu, A Scorilas, A Magklara, et al.
Anticancer Research|March 16, 2004
In-silico analysis of kallikrein gene expression in pancreatic and colon cancersGeorge M Yousef, Carla A Borgoño, Cynthia Popalis, et al.
BMC Cancer|July 17, 2019
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancerWeiwei Gong, Yueyang Liu, Christof Seidl, et al.
Clinical Chemistry and Laboratory Medicine|June 18, 2021
Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assayDouglas D Fraser, Michelle Chen, Annie Ren, et al.
Tissue Engineering. Part A|October 16, 2014
Collagen type XII and versican are present in the early stages of cartilage tissue formation by both redifferentating passaged and primary chondrocytesDrew W Taylor, Nazish Ahmed, Justin Parreno, et al.
Biological Chemistry|August 26, 2014
Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancerFrancine Walker, Pascal Nicole, Abdelhak Jallane, et al.
Biochemical and Biophysical Research Communications|July 25, 2003
Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitorsAngeliki Magklara, Ali A Mellati, Gregory A Wasney, et al.
Clinical Biochemistry|February 20, 2004
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementiaEleftherios P Diamandis, Andreas Scorilas, Tadaaki Kishi, et al.
Pageof 79